Effects of topical sphingosine-1-phosphate 1 receptor agonist on corneal allograft in mice

Cornea

Volumn 33, Issue 4, 2014, Pages 398-404

  Jia, Liang ^a   Liu, Yong ^b   Wang, Liqiang ^a   Zhu, Jing ^a   Huang, Yifei ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b AIR FORCE GENERAL HOSPITAL   (China)

Author keywords

corneal allograft; cyclosporine A; dendritic cells; sphingosine 1 phosphate 1 receptor

Indexed keywords

AGENTS ACTING ON THE EYE; CYCLOSPORIN A; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; INTERLEUKIN 2; SPHINGOSINE 1 PHOSPHATE RECEPTOR AGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORNEA TRANSPLANTATION; DENDRITIC CELL; GRAFT REJECTION; GRAFT SURVIVAL; HISTOPATHOLOGY; INFLAMMATORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADMINISTRATION, TOPICAL; ALLOGRAFTS; ANIMALS; ANTIGENS, CD86; CORNEA; CORNEAL TRANSPLANTATION; CTLA-4 ANTIGEN; CYCLOSPORINE; DENDRITIC CELLS; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNE TOLERANCE; IMMUNOSUPPRESSIVE AGENTS; INTERFERON-GAMMA; INTERLEUKIN-2; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MODELS, ANIMAL; OPHTHALMIC SOLUTIONS; PROPYLENE GLYCOLS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, LYSOSPHINGOLIPID; RNA, MESSENGER; SPHINGOSINE;

EID: 84896391773     PISSN: 02773740     EISSN: 15364798     Source Type: Journal    
DOI: 10.1097/ICO.0000000000000077     Document Type: Article

References (41)

1. Rocha G, Deschênes J, Rowsey JJ. The immunology of corneal graft rejection. Crit Rev Immunol. 1998;18:305-325
2. Coster DJ, Williams KA. The impact of corneal allograft rejection on the long-Term outcome of corneal transplantation. Am J Ophthalmol. 2005; 140:1112-1122
3. Claesson M, Armitage WJ, Fagerholm P, et al. Visual outcome in corneal grafts: A preliminary analysis of the Swedish Corneal Transplant Register. Br J Ophthalmol. 2002;86:174-180
4. Panda A, Vanathi M, Kumar A, et al. Corneal graft rejection. Surv Ophthalmol. 2007;52:375-396
5. Inoue K, Kimura C, Amano S, et al. Long-Term outcome of systemic cyclosporine treatment following penetrating keratoplasty. Jpn J Ophthalmol. 2001;45:378-382
6. Shimazaki J, Den S, Omoto M, et al. Prospective, randomized study of the efficacy of systemic cyclosporine in high-risk corneal transplantation. Am J Ophthalmol. 2011;152:33-39.e1
7. Liu Y, Jiang J, Xiao H, et al. Topical application of FTY720 and cyclosporin A prolong corneal graft survival in mice. Mol Vis. 2012;18:624-633
8. Mandala S, Hajdu R, Bergstrom J, et al. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science. 2002; 296:346-349
9. Skoura A, Sanchez T, Claffey K, et al. Essential role of sphingosine 1-phosphate receptor 2 in pathological angiogenesis of the mouse retina. J Clin Invest. 2007;117:2506-2516
10. Deng Q, Clemas JA, Chrebet G, et al. Identification of Leu276 of the S1P1 receptor and Phe263 of the S1P3 receptor in interaction with receptor specific agonists by molecular modeling, site-directed mutagenesis, and affinity studies. Mol Pharmacol. 2007;71:724-735
11. Liu Y, Hamrah P, Zhang Q, et al. Draining lymph nodes of corneal transplant hosts exhibit evidence for donor major histocompatibility complex (MHC) class II-positive dendritic cells derived from MHC class II-negative grafts. J Exp Med. 2002;195:259-268
12. Hamrah P, Liu Y, Zhang Q, et al. The corneal stroma is endowed with a significant number of resident dendritic cells. Invest Ophthalmol Vis Sci. 2003;44:581-589
13. Zhang EP, Schründer S, Hoffmann F. Orthotopic corneal transplantation in the mouse-A new surgical technique with minimal endothelial cell loss. Graefes Arch Clin Exp Ophthalmol. 1996;234:714-719
14. Larkin DF, Calder VL, Lightman SL. Identification and characterization of cells infiltrating the graft and aqueous humour in rat corneal allograft rejection. Clin Exp Immunol. 1997;107:381-391
15. Xie Y, Sun HX, Li D. Platycodin D is a potent adjuvant of specific cellular and humoral immune responses against recombinant hepatitis B antigen. Vaccine. 2009;27:757-764
16. Zhang JL, Sun DJ, Hou CM, et al. CD3 mAb treatment ameliorated the severity of the cGVHD-induced lupus nephritis in mice by up-regulation of Foxp3+ regulatory T cells in the target tissue: Kidney. Transpl Immunol. 2010;24:17-25
17. Niederkorn JY. Immune mechanisms of corneal allograft rejection. Curr Eye Res. 2007;32:1005-1016
18. Küchle M, Cursiefen C, Nguyen NX, et al. Risk factors for corneal allograft rejection: Intermediate results of a prospective normal-risk keratoplasty study. Graefes Arch Clin Exp Ophthalmol. 2002;240: 580-584
19. Williams KA, Lowe M, Bartlett C, et al. Risk factors for human corneal graft failure within the Australian corneal graft registry. Transplantation. 2008;86:1720-1724
20. Alalwani H, Omer Saleh B, Rocher N, et al. Advantages and limits of multiple grafts (third keratoplasty) under local cyclosporin 2% [in French]. J Fr Ophtalmol. 2010;33:710-714
21. Bourges JL, Lallemand F, Agla E, et al. Evaluation of a topical cyclosporine A prodrug on corneal graft rejection in rats. Mol Vis. 2006;12: 1461-1466
22. Poon A, Constantinou M, Lamoureux E, et al. Topical Cyclosporin A in the treatment of acute graft rejection: A randomized controlled trial. Clin Experiment Ophthalmol. 2008;36:415-421
23. Sinha R, Jhanji V, Verma K, et al. Efficacy of topical cyclosporine A 2% in prevention of graft rejection in high-risk keratoplasty: A randomized controlled trial. Graefes Arch Clin Exp Ophthalmol. 2010;248:1167-1172
24. Unal M, Yücel I. Evaluation of topical ciclosporin 0.05% for prevention of rejection in high-risk corneal grafts. Br J Ophthalmol. 2008;92: 1411-1414
25. Boisgérault F, Liu Y, Anosova N, et al. Differential roles of direct and indirect allorecognition pathways in the rejection of skin and corneal transplants. Transplantation. 2009;87:16-23
26. Huq S, Liu Y, Benichou G, et al. Relevance of the direct pathway of sensitization in corneal transplantation is dictated by the graft bed microenvironment. J Immunol. 2004;173:4464-4469
27. Sonoda Y, Streilein JW. Orthotopic corneal transplantation in mice-evidence that the immunogenetic rules of rejection do not apply. Transplantation. 1992;54:694-704
28. Yamada J, Ksander BR, Streilein JW. Cytotoxic T cells play no essential role in acute rejection of orthotopic corneal allografts in mice. Invest Ophthalmol Vis Sci. 2001;42:386-392
29. Allende ML, Dreier JL, Mandala S, et al. Expression of the sphingosine 1-phosphate receptor, S1P1, on T-cells controls thymic emigration. J Biol Chem. 2004;279:15396-15401
30. Matloubian M, Lo CG, Cinamon G, et al. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature. 2004;427:355-360
31. Sanna MG, Liao J, Jo E, et al. Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate. J Biol Chem. 2004;279:13839-13848
32. Cinamon G, Matloubian M, Lesneski MJ, et al. Sphingosine 1-phosphate receptor 1 promotes B cell localization in the splenic marginal zone. Nat Immunol. 2004;5:713-720
33. Idzko M, Panther E, Corinti S, et al. Sphingosine 1-phosphate induces chemotaxis of immature and modulates cytokine-release in mature human dendritic cells for emergence of Th2 immune responses. FASEB J. 2002; 16:625-627
34. Trombetta ES, Mellman I. Cell biology of antigen processing in vitro and in vivo. Annu Rev Immunol. 2005;23:975-1028
35. Chow A, Toomre D, Garrett W, et al. Dendritic cell maturation triggers retrograde MHC class II transport from lysosomes to the plasma membrane. Nature. 2002;418:988-994
36. Turley SJ, Inaba K, Garrett WS, et al. Transport of peptide-MHC class II complexes in developing dendritic cells. Science. 2000;288:522-527
37. Boes M, Cerny J, Massol R, et al. T-cell engagement of dendritic cells rapidly rearranges MHC class II transport. Nature. 2002;418:983-988
38. Perez VL, Van Parijs L, Biuckians A, et al. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity. 1997;6:411-417
39. Kobayashi T, Momoi Y, Iwasaki T. Cyclosporine A inhibits the mRNA expressions of IL-2, IL-4 and IFN-gamma, but not TNF-Alpha, in canine mononuclear cells. J Vet Med Sci. 2007;69:887-892
40. Tian L, Stepkowski SM, Qu X, et al. Cytokine mRNA expression in tolerant heart allografts after immunosuppression with cyclosporine, sirolimus or brequinar. Transpl Immunol. 1997;5:189-198
41. Fruman DA, Klee CB, Bierer BE, et al. Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A. Proc Natl Acad Sci U S A. 1992;89:3686-3690